Mak, Lung-Yi
Queen Mary Hospital · University of Hong Kong
5 papers on CoChatORCID 0000-0002-2266-3935
Most cited papers
- Verified
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance
Mak, L.-Y., Wong, D. K.-H., Pollicino, T., Raimondo, G., Hollinger, F. B., & Yuen, M.-F. (2020) · Journal of Hepatology
Hepatitis B Virus StudiesHepatitis C virus research
Cited by 223
- Verified
Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B
Mak, L.-Y., Hui, R. W.-H., Fung, J., Liu, F., Wong, D. K.-H., Cheung, K.-S., Yuen, M.-F., & Seto, W.-K. (2020) · Journal of Hepatology
Hepatitis B Virus StudiesLiver Disease Diagnosis and Treatment
Cited by 152
- Verified
Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case‐control study
Hui, R. W. H., Seto, W. ‐., Cheung, K. ‐., Mak, L. ‐., Liu, K. S. H., Fung, J., Wong, D. K. ‐., Lai, C. ‐., & Yuen, M. ‐. (2018) · Journal of Viral Hepatitis
Liver Disease Diagnosis and TreatmentHepatitis B Virus Studies
Cited by 128
- Verified
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
Mak, L.-Y., Gane, E., Schwabe, C., Yoon, K. T., Heo, J., Scott, R., Lee, J.-H., Lee, J. I., Kweon, Y. O., Weltman, M., et al. (2023) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentRNA Interference and Gene Delivery
Cited by 98
- Verified
Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection
Mak, L.-Y., Hui, R. W.-H., Fung, J., Liu, F., Wong, D. K.-H., Li, B., Cheung, K.-S., Yuen, M.-F., & Seto, W.-K. (2021) · Hepatology International
Liver Disease Diagnosis and TreatmentHepatitis B Virus Studies
Cited by 58
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free